Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
ORLive -- Your Destination for Live and On-Demand Surgery Video - Market Wire (press release)
ORLive -- Your Destination for Live and On-Demand Surgery Video Market Wire (press release) HCC, the most common form of , is diagnosed in about 24100 people each year. Watch this webcast to learn more about the latest advances in the ... |
De-liver me from cancer - Malaysia Star
De-liver me from cancer Malaysia Star The liver is a silent, faithful partner and does not complain UNTIL advanced damage has occurred. What is ? Primary is the fifth ... |
Study finds elevated rates of cancer in Crestwood - Chicago Tribune
 Chicago Tribune | Study finds elevated rates of cancer in Crestwood Chicago Tribune There were no cases of angiosarcoma, a linked to vinyl chloride exposure. But the finding wasn't surprising because that type of cancer is ... |
U.S. Doctors Sanction Transplant Criteria For Patients - Eurasia Review
U.S. Doctors Sanction Transplant Criteria For Liver Cancer Patients Eurasia Review The National Cancer Institute estimates that more than 16000 men and over 6000 women in the US will be diagnosed with , and over 18000 liver ... |
The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice - 7thSpace Interactive (press release)
The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice 7thSpace Interactive (press release) This suggests that c-Jun inhibition may serve as a therapeutic target for . The c-Jun dimerization protein 2, JDP2 is an AP-1 repressor protein ... |
Celsion moving to second trials of drug - Baltimore Business Journal
Celsion moving to second trials of liver cancer drug Baltimore Business Journal Celsion Corp. is moving into the second phase of clinical trials for its drug to treat . The Columbia biotechnology company said Monday that ... Celsion Plans to Launch Phase II Program to Study ThermoDox(R) in Combination ... |
Provectus Pharmaceuticals Executes Purchase Agreements for Approximately $5.3 ... - Trading Markets (press release)
Provectus Pharmaceuticals Executes Purchase Agreements for Approximately $5.3 ... Trading Markets (press release) Its oncology focus is on melanoma, breast cancer and metastatic . The Company has received orphan drug designation from the FDA for its melanoma ... |
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales - BusinessWeek
 BNET | OSI Bid Likely to Rise as Astellas Seeks Cancer Sales BusinessWeek Onyx Pharmaceuticals Inc., maker of the kidney and drug Nexavar, would be less appealing to buyers because its partnership with Bayer AG would ... Big Biotech M&A Targets: Who Could Follow Astellas' $3.5B Bid for OSI? Who's the next biotech buyout target? |
Early Liver Detection Methods Ineffective - BusinessWeek
Early Liver Detection Methods Ineffective BusinessWeek 26 (HealthDay News) -- New research suggests that biomarkers used to detect in its early stages aren't doing a great job. ... |
Electrocuting ? - ABC7Chicago.com
 Momento24 English | Electrocuting Liver Cancer? ABC7Chicago.com March 8, 2010 -- According to the National Cancer Institute, more than 22000 cases of were diagnosed last year, and the disease caused more ... A giant tumor was removed from a man |